Literature DB >> 15558522

Anemia and health-related quality of life in adolescents with chronic kidney disease.

Arlene Gerson1, Wenke Hwang, Jeffrey Fiorenza, Katherine Barth, Frederick Kaskel, Lynne Weiss, Nataliya Zelikovsky, Barbara Fivush, Susan Furth.   

Abstract

BACKGROUND: A number of studies of adults with chronic kidney disease (CKD) have shown a negative impact of anemia on several aspects of health-related quality of life (HRQOL). Although similar links have been suggested in adolescent dialysis populations, the relationship between anemia and HRQOL in children not requiring dialysis therapy has yet to be studied extensively in a large sample.
METHODS: We examined the association between anemia and HRQOL in baseline data collected on a prospective cohort of adolescents with CKD by using a generic HRQOL questionnaire completed by parents or caregivers (Child Health Questionnaire Parent Form [CHQ-PF50]). Our study population included guardians or caregivers of 105 adolescents (mean age, 14 +/- 2 years) with stages 1 to 5 CKD as defined by the National Kidney Foundation-Kidney Disease Outcomes Quality Initiative, including subjects with chronic renal insufficiency, patients with functioning kidney transplants, and dialysis patients.
RESULTS: Seventy of 105 patients were classified in the study as anemic according to a hematocrit value of 36% or less. Compared with the group with higher hematocrit values and independent of sex, race, and estimated glomerular filtration rate, anemic patients reported greater limitations in CHQ-PF50 domains relating to (1) physical functioning, (2) limitations in schoolwork or activities with friends as a result of physical health, and (3) parental impact in time and family activities.
CONCLUSION: Anemia was associated with lower quality of life in adolescents across the spectrum of stages of CKD. Future studies should address the effect of interventions to improve anemia on HRQOL.

Entities:  

Mesh:

Year:  2004        PMID: 15558522     DOI: 10.1053/j.ajkd.2004.08.024

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  59 in total

1.  The association of anemia and hypoalbuminemia with accelerated decline in GFR among adolescents with chronic kidney disease.

Authors:  Susan L Furth; Stephen R Cole; Jeffrey J Fadrowski; Arlene Gerson; Christopher B Pierce; Manju Chandra; Robert Weiss; Frederick Kaskel
Journal:  Pediatr Nephrol       Date:  2006-11-21       Impact factor: 3.714

2.  Darbepoetin alfa for the treatment of anemia in pediatric patients with chronic kidney disease.

Authors:  Bradley A Warady; Mazen Y Arar; Gary Lerner; Arline M Nakanishi; Catherine Stehman-Breen
Journal:  Pediatr Nephrol       Date:  2006-05-25       Impact factor: 3.714

3.  Anemia treatment with Q2W darbepoetin alfa in patients with chronic kidney disease naïve to erythropoiesis-stimulating agents.

Authors:  M R Silver; R Geronemus; M Krause; C Y Chen; R Kewalramani; C Stehman-Breen
Journal:  Curr Med Res Opin       Date:  2009-01       Impact factor: 2.580

4.  Early Requirement for RRT in Children at Presentation in the United Kingdom: Association with Transplantation and Survival.

Authors:  Rishi Pruthi; Anna Casula; Carol Inward; Paul Roderick; Manish D Sinha
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-15       Impact factor: 8.237

5.  Timing of erythropoiesis-stimulating agent initiation and adverse outcomes in nondialysis CKD: a propensity-matched observational study.

Authors:  Stephen Seliger; Kathleen M Fox; Shravanthi R Gandra; Brian Bradbury; Van Doren Hsu; Loreen Walker; Chiun-Fang Chiou; Jeffrey C Fink
Journal:  Clin J Am Soc Nephrol       Date:  2010-03-18       Impact factor: 8.237

6.  Using a non-invasive method in chronic hemodialysis pediatric patients to estimate hemoglobin.

Authors:  Jessica J Geer; Michael C Braun; Poyyapakkam R Srivaths
Journal:  Pediatr Nephrol       Date:  2014-10-17       Impact factor: 3.714

Review 7.  Chronic Kidney Disease and Dietary Measures to Improve Outcomes.

Authors:  Oleh M Akchurin
Journal:  Pediatr Clin North Am       Date:  2019-02       Impact factor: 3.278

8.  Peginesatide for maintenance treatment of anemia in hemodialysis and nondialysis patients previously treated with darbepoetin alfa.

Authors:  Steven Fishbane; Simon D Roger; Edouard Martin; Grant Runyan; Janet O'Neil; Ping Qiu; Francesco Locatelli
Journal:  Clin J Am Soc Nephrol       Date:  2012-12-14       Impact factor: 8.237

Review 9.  Lessons learned from the ESPN/ERA-EDTA Registry.

Authors:  Jérôme Harambat; Marjolein Bonthuis; Jaap W Groothoff; Franz Schaefer; E Jane Tizard; Enrico Verrina; Karlijn J van Stralen; Kitty J Jager
Journal:  Pediatr Nephrol       Date:  2015-10-24       Impact factor: 3.714

10.  Anemia and risk of hospitalization in pediatric chronic kidney disease.

Authors:  Amy O Staples; Craig S Wong; Jodi M Smith; Debbie S Gipson; Guido Filler; Bradley A Warady; Karen Martz; Larry A Greenbaum
Journal:  Clin J Am Soc Nephrol       Date:  2008-12-03       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.